RxDoctor Payments Data

Rachel Koch

Gerontology · Philadelphia, PANPI 1295431807

Payments from drug & device makers

$619in general payments, 2019–2025

Across 28 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$146
  • Johnson & Johnson$97
  • AstraZeneca$78
  • Novartis$54
  • Phathom Pharmaceuticals, Inc.$41
  • Pharmacosmos Therapeutics Inc.$26
  • plus $177 from 9 others

What the payments were for

  • Food & beverage$619100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$619 in reported general payments places this provider in the 70th percentile of 383 gerontology providers in Pennsylvania.

See all gerontology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$10,125
Medicare patients
70
Services billed
154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImbruvicaIbrutinib29$451,940
CalquenceAcalabrutinib Maleate13$190,758
Gammagard S-DImmun Glob G/Gly/Gluc/Iga 0-5011$97,607
Atovaquone12$2,968
Ondansetron Hcl21$418
Gabapentin19$285
Lidocaine Hcl ViscousLidocaine Hcl18$250
Acyclovir27$238
Potassium Chloride13$224
Prednisone22$180
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$130
Famotidine12$125
Olanzapine11$59

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaCalquence$78$190,75813 claims
Lilly USA, LLCOlanzapine$18$5911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 383 gerontology providers in Pennsylvania.

Other gerontology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →